Disorders of the immune status in patients with chronic cerebral ischemia; differentiated pharmacological correction
Introduction: Chronic cerebral ischemia (CCI) accounts for 60-75% of all cerebrovascular diseases in Russia and around the world. The problem: the issues concerning the role of immunity in the pathogenesis of CCI depending on the main etiologic factor and stage of the disease are hardly elaborated,...
Main Authors: | Anastasiya A. Shulginova, Alexander I. Konoplya, Natalya A. Bystrova |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2018-06-01
|
Series: | Research Results in Pharmacology |
Online Access: | https://rrpharmacology.pensoft.net/article/28304/download/pdf/ |
Similar Items
-
CORRECTION OF IMMUNE DISTURBANCES IN CHRONIC CEREBRAL ISCHEMIA
by: A. A. Shulginova, et al.
Published: (2018-06-01) -
PERSONALIZED PHARMACOLOGICAL CORRECTION OF IMMUNE SYSTEMS, METABOLIC AND NEUROPSYCHIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA OF STAGE I AND II ON THE BACKGROUND OF HYPERTENSION DISEASE
by: A. I. Konoplya, et al.
Published: (2021-10-01) -
CORRELATION ANALYSIS BETWEEN LABORATORY IMMUNE AND METABOLIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA STAGES I AND II ALONG WITH HYPERTENSION AFTER TREATMENT
by: N. A. Bystrova, et al.
Published: (2021-10-01) -
Proteins of allogeneic hepatocytes and pharmacological preparations for the correction of immunometabolic disorders in experimental liver pathology
by: Ekaterina S. Litvinova, et al.
Published: (2021-06-01) -
PHARMACOLOGICAL MANAGEMENT OF IMMUNE AND OXIDATIVE DISTURBANCES IN PATIENTS WITH ENCEPHALOPATHY ON THE BACKGROUND OF HYPERTENSION
by: Anastasiya Shulginova, et al.
Published: (2016-06-01)